Achieve Your Wellness Goals with Glow with Kelly

 Full-dose GLP-1 medications (like Semaglutide or Tirzepatide) are FDA-approved for weight management or type 2 diabetes, usually with specific BMI or health criteria. But not everyone fits that criteria, and not everyone wants to start at a therapeutic dose right away.

That's where "microdosing" comes in — using a smaller-than-standard amount of the same medications. It's become popular through telehealth platforms as a lower-commitment entry point, though it's worth knowing this is an off-label, provider-directed approach rather than an FDA-approved protocol with its own clinical trials.

People using low-dose GLP-1s often mention:

• Reduced appetite — fewer cravings and less "grazing"
• More stable blood sugar — fewer energy crashes
• Gradual, modest weight changes — slower than full-dose protocols
• A gentler side-effect profile — full-dose GLP-1s are known for nausea/GI issues, and lower doses tend to cause less of that

Keep in mind: at low doses, effects are generally smaller and slower than the outcomes seen in the large weight-loss trials, which used therapeutic (not micro) doses.

• It still requires a prescription. Any legitimate provider will have you complete a health history and questionnaire, and a licensed clinician should review it — this isn't a supplement.
• Evidence for "microdosing" specifically is thin. Most GLP-1 research has studied standard therapeutic doses. Low-dose use is more clinical judgment/emerging practice than an established protocol.
• Side effects still apply, even if milder — nausea, GI upset, and rarely more serious reactions (pancreatitis, gallbladder issues) are things to watch for.
• It's not a substitute for a conversation with a doctor about whether it's appropriate for your health history, especially if you're on other medications or have GI, thyroid, or pancreatic conditions.